Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience
- 1 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 52 (1), 158-160
- https://doi.org/10.1007/s11239-020-02293-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular ThrombiJAMA Cardiology, 2020
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial FibrillationJournal of the American College of Cardiology, 2019
- Use of Direct Oral Anticoagulants Among Patients With Limited Income and ResourcesJournal of the American College of Cardiology, 2019
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeBlood, 2018
- Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device PatientsCirculation: Heart Failure, 2017
- Antithrombotic Therapy for VTE DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2016
- Dabigatran versus Warfarin in Patients with Mechanical Heart ValvesThe New England Journal of Medicine, 2013